Physicians at the Massachusetts GeneralHospital Cancer Center have become leaders in the development of personalized medicine for cancer patients. Specifically, years of collaborative research among clinicians, pathologists and molecular biologists have led to the development of better and faster methods to "genotype"
cancers and identify the genetic abnormalities that drive particular tumors. In turn, these methods are giving rise to new treatment paradigms focused on genetic mutations that may be shared by different tumors, irrespective
of their tissue of origin.
To learn more, or see if you qualify for a clinical trial visit: http://www.massgeneral.org/genotyping/index.html?utm_source=mni&utm_medi...
